Report of the Commission on Intellectual Property Rights, Innovation and Public Health: a call to governments.
作者信息
't Hoen Ellen
机构信息
Access to Essential Medicines Campaign, Médecins sans Frontières, Paris, France.
出版信息
Bull World Health Organ. 2006 May;84(5):421-3. doi: 10.2471/blt.06.032391. Epub 2006 May 17.
Abstract
摘要
相似文献
1
Report of the Commission on Intellectual Property Rights, Innovation and Public Health: a call to governments.知识产权、创新与公共卫生委员会报告：向各国政府发出的呼吁。
Bull World Health Organ. 2006 May;84(5):421-3. doi: 10.2471/blt.06.032391. Epub 2006 May 17.
2
The right to health and medicines: the case of recent multilateral negotiations on public health, innovation and intellectual property.健康权与药品：近期关于公共卫生、创新与知识产权的多边谈判情况
Dev World Bioeth. 2014 Aug;14(2):67-74. doi: 10.1111/dewb.12049. Epub 2014 May 12.
3
Global health and Brazilian foreign policy: the negotiations on innovation and intellectual property.全球健康与巴西外交政策：关于创新与知识产权的谈判
Cien Saude Colet. 2017 Jul;22(7):2213-2221. doi: 10.1590/1413-81232017227.02652017.
4
Report of the Commission on Intellectual Property Rights, Innovation and Public Health: an industry perspective.知识产权、创新与公共卫生委员会报告：行业视角
Bull World Health Organ. 2006 May;84(5):419-20. doi: 10.2471/blt.06.032417. Epub 2006 May 17.
5
Trade agreements, intellectual property, and the role of the World Bank in improving access to medicines in developing countries.贸易协定、知识产权以及世界银行在改善发展中国家药品可及性方面的作用。
Yale J Health Policy Law Ethics. 2004 Summer;4(2):401-13.
6
Health and intellectual property rights.健康与知识产权。
Bull World Health Organ. 2001;79(5):381.
7
Patents & public health: international trade obligations and domestic policy development.专利与公共卫生：国际贸易义务及国内政策发展
Health Law Can. 2002 Feb;22(3):76-84.
8
Public health, innovation and intellectual property rights: unfinished business.公共卫生、创新与知识产权：未竟之事。
Bull World Health Organ. 2006 May;84(5):338. doi: 10.2471/blt.06.031880. Epub 2006 May 17.
9
The ethics of intellectual property rights in an era of globalization.全球化时代的知识产权伦理
J Law Med Ethics. 2013 Winter;41(4):841-51, Table of Contents. doi: 10.1111/jlme.12094.
10
CIPIH report: main recommendations.国际健康影响评估委员会报告：主要建议。
Bull World Health Organ. 2006 May;84(5):351. Epub 2006 May 17.
引用本文的文献
1
The Political Economy of the World Health Organization Model Lists of Essential Medicines.世界卫生组织基本药物示范清单的政治经济学
Milbank Q. 2025 Mar;103(1):52-99. doi: 10.1111/1468-0009.70001. Epub 2025 Feb 27.
2
Trends in compulsory licensing of pharmaceuticals since the Doha Declaration: a database analysis.《多哈宣言》之后药品强制许可的趋势：数据库分析。
PLoS Med. 2012 Jan;9(1):e1001154. doi: 10.1371/journal.pmed.1001154. Epub 2012 Jan 10.
3
One step forward, one step sideways? Expanding research capacity for neglected diseases.向前一步，还是 sideways？拓展被忽视疾病的研究能力。
BMC Int Health Hum Rights. 2010 Jul 14;10:20. doi: 10.1186/1472-698X-10-20.
4
Three Proposals for Rewarding Novel Health Technologies Benefiting People Living in Poverty. A Comparative Analysis of Prize Funds, Health Impact Funds and a Cost-Effectiveness/Competitive Tender Treaty.奖励造福贫困人口的新型健康技术的三项提议。奖金基金、健康影响基金及成本效益/竞争性招标条约的比较分析。
Public Health Ethics. 2008 Jul;1(2):146-153. doi: 10.1093/phe/phn013. Epub 2008 May 3.
5
Understanding and improving access to prompt and effective malaria treatment and care in rural Tanzania: the ACCESS Programme.了解并改善坦桑尼亚农村地区获得及时有效疟疾治疗和护理的途径：ACCESS项目。
Malar J. 2007 Jun 29;6:83. doi: 10.1186/1475-2875-6-83.
6
Monopolizing clinical trial data: implications and trends.垄断临床试验数据：影响与趋势
PLoS Med. 2007 Feb;4(2):e2. doi: 10.1371/journal.pmed.0040002.
Zotero 插件